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Abstract 
Rationale: Treating diseases of the brain such as Alzheimer's disease (AD) is challenging as the blood-brain 
barrier (BBB) effectively restricts access of a large number of potentially useful drugs. A potential solution to 
this problem is presented by therapeutic ultrasound, a novel treatment modality that can achieve transient BBB 
opening in species including rodents, facilitated by biologically inert microbubbles that are routinely used in a 
clinical setting for contrast enhancement. However, in translating rodent studies to the human brain, the 
presence of a thick cancellous skull that both absorbs and distorts ultrasound presents a challenge. A larger 
animal model that is more similar to humans is therefore required in order to establish a suitable protocol and 
to test devices. Here we investigated whether sheep provide such a model. 
Methods: In a stepwise manner, we used a total of 12 sheep to establish a sonication protocol using a 
spherically focused transducer. This was assisted by ex vivo simulations based on CT scans to establish suitable 
sonication parameters. BBB opening was assessed by Evans blue staining and a range of histological tests.  
Results: Here we demonstrate noninvasive microbubble-mediated BBB opening through the intact sheep 
skull. Our non-recovery protocol allowed for BBB opening at the base of the brain, and in areas relevant for 
AD, including the cortex and hippocampus. Linear time-shift invariant analysis and finite element analysis 
simulations were used to optimize the position of the transducer and to predict the acoustic pressure and 
location of the focus.  
Conclusion: Our study establishes sheep as a novel animal model for ultrasound-mediated BBB opening and 
highlights opportunities and challenges in using this model. Moreover, as sheep develop an AD-like pathology 
with aging, they represent a large animal model that could potentially complement the use of non-human 
primates. 
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Introduction 
Routinely used in the medical field for 
diagnostic imaging, ultrasound is increasingly being 
explored for its neuromodulatory and also 
therapeutic potential (either as a neurosurgical tool 
for tissue coagulation or for the delivery of 
therapeutic agents to the brain). However, the human 
skull presents a challenge as it consists of two layers 
of cortical bone and a central layer with liquid-filled 
pores, which can both reflect and distort ultrasound, 
thereby dampening the pressure wave and heating 
the bone [1]. This problem has been partially 
addressed using phased array systems, which allow 
for tissue coagulation by focusing continuous high 
energy ultrasound waves [2,3]. In the case of drug 
delivery, low energy-pulsed ultrasound is being used 
in a protocol that involves interaction with 
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intravenously injected microbubbles to achieve a 
transient opening of the blood-brain barrier (BBB) in a 
process we have conveniently termed obicodilation 
[4]. Both simple transducer systems and more 
complex phased arrays have been used [5]. An 
alternative strategy requires craniotomy to implant a 
transducer in a fixed position. This circumvents the 
need to transmit ultrasound through the skull bone 
but the method also has its limitations [6]. A series of 
studies has been conducted to determine the most 
critical ultrasound parameters for BBB opening [7]. 
These include the acoustic pressure [8], transducer 
frequency [9], pulse repetition frequency [10], 
microbubble size [11], and pulse duration (burst 
duration) [10]. The mechanical index has been 
presented as a metric that describes the threshold for 
BBB opening, being proportional to peak negative 
pressure and inversely proportional to center 
frequency [12], such that lower frequencies have a 
lower pressure threshold for BBB opening. The time 
taken for BBB closure was found to be independent of 
the opening volume [13], and the amount of opening 
was reduced by breathing pure oxygen as opposed to 
air [14]. However, despite considerable progress, 
accessing the human brain to achieve therapeutic 
outcomes with ultrasound has remained a challenge, 
in terms of the treatment of large areas and 
overcoming the thickness of the skull and the 
heterogeneity of the brain itself.  
 Obicodilation has mostly been evaluated in 
rodents, which have a thin skull that does not present 
a major barrier for ultrasound transmission. Brain 
uptake has been demonstrated for MRI contrast 
agents [15,16], fluorescently labeled dextrans [17] and 
the dye Evans blue [18,19], which are normally 
excluded from the brain. Brain uptake of an antibody 
targeting amyloid plaques was shown to increase in a 
mouse model for Alzheimer's disease (AD) [20], and 
obicodilation also proved effective and safe in 
removing toxic protein aggregates in AD mouse 
models, either in combination with a therapeutic 
antibody [21,22], or on its own [19,22-25], with a 
concomitant improvement in memory [19,22,24]. 
More extensive safety studies, both short- and 
long-term, have also been performed in wild-type 
mice [8,10,12,26,27]. 
On the road to translation, the work in rodents 
continues to inspire research using larger animals, 
including dogs, miniature pigs and macaques [28-31]. 
Here, we established sheep (a species previously 
treated with ultrasound to induce thermal lesions 
[32]) as an experimental system for obicodilation, our 
rationale being that their skull is close to that of 
humans in regards to thickness, porosity and the 
curvature of the calvarium [32] (Figure 1). This 
similarity also extends to the morphology of the brain, 
which, although smaller than that of humans, is also 
non-homogenous and gyrencephalic [33]. Finally, 
sheep can also live for at least 10 years and develop an 
AD-like pathology with age, further underscoring the 
attractiveness of this model for dementia research 
[34].  
 
 
Figure 1. Brain mass versus skull thickness. Comparison of average brain mass 
(y-axis) and skull thickness for species currently used in ultrasound-mediated 
obicodilation studies.  
 
 In the current study, we developed a stepwise 
optimization protocol and performed ex vivo 
measurements and simulations to obtain information 
about focusing ultrasound through the sheep skull 
and the attenuation and heating that this causes. To 
achieve targeting of cortical areas and the 
hippocampus, we performed finite element analysis 
(FEA) simulations and successfully predicted that a 20 
mm coupling cone was required to target these brain 
areas. We anticipate that our study will guide the 
future use of sheep in preclinical studies of ultrasound 
devices for the treatment of diseases of the brain.  
Methods  
Animal species and ethics  
Twelve 3-8-year-old female Merino sheep 
(average age: 6.75 years, average weight: 54.5 kg) 
were used in this study (Table 1), which was 
approved by the Animal Ethics Committee of the 
Queensland University of Technology (QUT ethics 
approval # 1500000509) and ratified by the University 
of Queensland. 
In vivo sonication procedure and dissection of 
sheep brain and skull 
A flowchart of the procedure is provided in 
Figure S1. The sheep were positioned in sternal 
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recumbency on a surgical trolley and ventilated 
throughout the procedure with 2-2.5% isoflurane and 
30% oxygen, on 10 breaths/min, and with a tidal 
volume of 500 mL. Anesthesia was introduced with 
propofol (4 mg/kg, i.v.; Provive, Claris Lifesciences 
Australia, Sydney, Australia) and maintained with 
isoflurane (IsoFlo, Zoetis, Parsippany-Troy Hills, NJ). 
Jugular vein cannulation was used to allow for the 
administration of the microbubbles and Evans blue 
dye. Prior to sonication, the sheep’s head was shaved 
and fully depilated using Veet hair removal cream 
(Veet, Reckitt Benckiser, Slough, UK).  
 A spherically focused high-intensity focused 
ultrasound (HIFU) transducer was then positioned on 
the head using a coupling cone or placed directly onto 
the skull (Figure 2A-B). Ultrasound gel was applied to 
ensure good coupling. The sheep were sonicated in 
the presence of microbubbles using different 
parameters (Table 1), with a sonication time of 2 min 
per location (Figure 2C). Prior to injection, Definity 
microbubbles (Lantheus Medical Imaging, North 
Billerica, MA) were prepared and drawn into a 
syringe with a venting needle. Each bolus was 
administered at a clinical dose of 0.01 mL/kg body 
weight by injection into the jugular vein catheter, 
followed by a 5 mL saline flush and then immediate 
sonication. Note: custom-made microbubbles and 
continuous injection were initially explored, but then 
replaced by Definity microbubbles and bolus 
injections. A minimum of 5 min was allowed between 
multiple sonications for the microbubbles from the 
previous injection to mostly clear, as previously 
reported in beagles [31]. The mean half-life of Definity 
microbubbles is 1.3 min (according to product insert). 
 Evans blue dye (4% in saline) was administered 
immediately after the final sonication at a dose of 1.2 
mL/kg body weight, delivered with a syringe pump 
at a rate of 150 mL/h over 20 min. The total time from 
the first microbubble injection to initiating Evans blue 
infusion was approximately 30 min. The sheep were 
then euthanized using sodium pentobarbitone 
(Lethabarb, 100 mg/kg; Virbac Australia, Sydney, 
Australia). To prevent blood clotting, heparin (250 
IU/kg, i.v.; Pfizer Australia, Sydney, Australia) was 
given during the subsequent perfusion of saline and 
formalin through the carotid arteries and dissection of 
the brain. 
 After euthanasia, the sheep were decapitated 
and their heads flushed and perfused using 
administration sets (‘drips’) tied into the carotid 
arteries. Each carotid received two liters of saline 
flush, followed by one liter of 10% neutral-buffered 
formalin, delivered at a maximum drip rate. Once 
perfused, the brain was excised in one piece. First, the 
scalp was removed whole with a scalpel. Guide cuts 
were then made around the calvarium in an octagonal 
pattern using a cordless multi-tool (18V One+ 
multi-tool, Ryobi, Fuchu, Japan), after which plunge 
cuts were driven into the guides using a surgical bone 
saw (System 5 Sagittal Saw, Stryker, Kalamazoo, 
USA). Once the plunge cuts were sufficiently deep, a 
surgical chisel was used to separate any remaining 
connections between the calvarium and the skull, and 
to prise up the calvarium for removal in an octagonal 
pattern (Figure 2D). Once exposed, the brain was 
removed by inverting the head and applying gentle 
pressure with a finger through the foramen magnum 
(Figure 2E). The brain and calvarium were all 
post-fixed in 10% formalin overnight. The next day, 
the brain was sectioned coronally into 7 mm blocks 
using a house-made brain block (Figure 2F). The 
blocks were then again post-fixed in 10% formalin 
overnight, after which the tissue was stored in 
phosphate-buffered saline (PBS) containing 0.01% 
sodium azide. 
Computed tomography scanning 
For sheep 9-12, in vivo CT scanning of the head 
was performed after sonication and Evans blue 
infusion, but before euthanasia. While still 
anesthetized, the sheep were transferred to a CT 
scanner (Aquilon Lightning, Canon Medical Systems, 
Sydney, Australia), and scanned at 120 kV and 112 
mA, with a field of view of 220 mm, slice thickness 1 
mm, pixel size 0.43 mm and matrix 512x512.  
Ultrasound generation in vivo  
For the sheep study, pulses were generated with 
a function generator (Trueform 33512B, Keysight, 
Santa Rosa, CA), and amplified by 50 dB using a class 
A linear amplifier (240L Broadband Power Amplifier, 
Electronics & Innovation, Rochester, NY). Two 
different spherically focused HIFU transducers 
(H-107 at 500 kHz and H-117 at 286 kHz center 
frequency; f-number: 1, radius: 64 mm with a 20 mm 
central hole; Sonic Concepts, Bothell, WA) were used 
and driven at a range of voltages through an 
impedance matching network. The ultrasound 
parameters for the sheep procedures are shown in 
Table 1.  
Acoustic pressure mapping 
To perform acoustic measurements, an Onda 
AIMS III tank (Onda, Sunnyvale, CA) equipped with 
a calibrated needle hydrophone (HNR-500, Onda) and 
a 20 dB preamplifier (AH-2010, Onda) was used. A 
H-117 transducer was driven at 286 kHz, with 1 ms 
pulses, at 80 V, and a pulse repetition frequency (PRF) 
of 20 Hz.  
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Simulation of ultrasound acoustic response 
(UAR) analysis and experimental validation  
Linear time-shift invariant (LTI) systems 
investigate the response of a linear and time-invariant 
system to an arbitrary input signal. The behavior of 
the system is described by the mathematical 
expression of a ‘system transfer function’. Provided 
that the input and transfer function are known, the 
output can be calculated.  
 Ultrasound propagation can be represented by 
an LTI system; the trajectories of these systems can be 
tracked as they move through time. We recently 
introduced the concept of the ultrasound acoustic 
response (UAR) to determine how the geometry and 
material of bone phantoms affect the acoustic 
response, extending previous work that determined 
the transit time spectra (TTS) of ultrasound [35]. We 
grouped the pre-amplifier, hydrophone and HIFU 
transducer as an LTI system, used the excitation 
voltage generated by a waveform generator as input, 
and generated the measured voltage as output, 
determining the acoustic measurement versus time, 
captured by a hydrophone.  
 We were able to estimate the impact of the skull 
on the attenuation and delay of ultrasound waves 
using UAR (analyzed with MatLab software (The 
MathWorks Inc., Natick, MA) doing a Wiener 
deconvolution) [36,37]. Measurements were taken in 
the AIMS III tank using a needle hydrophone 
(HNR-500), comparing the signals recorded in the 
presence and absence of a sheep skull. The amplified 
received signal was sent to a data acquisition 
platform, which included a 16-bit high speed digitizer 
with 250 MS/s and 14 bit resolution (Spectrum, M4i 
platform), supported by the SBench 6 software 
(Spectrum, 
http://spectrum-instrumentation.com/en/sbench-6- 
overview).  
Simulation in ANSYS 
Finite element analysis (FEA) models a wide 
range of physical systems [38,39]. The ANSYS 
software (ANSYS® Academic Research, Release 17.2, 
Help System, ANSYS, Inc.) [40] was used with the 
FEA method to model acoustic waves transmitted 
from a HIFU and focused in the sheep brain, thereby 
estimating attenuation.  
These analyses compute a finite elements 
dynamic matrix equation: [MF]{ẍ e} + [KF]{xe} = {f F} 
where [𝑀𝑀𝐹𝐹] and [𝐾𝐾𝐹𝐹] are the equivalent fluid mass and 
stiffness matrices for the system, respectively, {𝑓𝑓𝐹𝐹} is 
an external excitation vector in the acoustic fluid, {𝑝𝑝𝑒𝑒} 
is a vector of unknown nodal acoustic pressure, and {?̈?𝑝𝑒𝑒} is a vector of the second derivative of acoustic 
pressure with respect to time [40]. 
 First, sheep skulls were scanned by CT (1 mm 
resolution) to create a 3D geometry of the skull cap 
(Figure 3A). The surface geometry, represented by 
triangle meshes, was simplified by 2 mm meshes to 
reduce the geometric complexity in the simulation 
(Figure 3B). The geometries of both the skull cap and 
the transducer were imported into the simulation 
domain to define the position of the transducer 
considering the distance and tilting angles relative to 
the skull cap according to preplanned sonication spots 
(Figure 3C).  
For the simulations, a speed of sound in the skull 
of 2,500 m/s (mean value using 2.25 MHz immersion 
transducers (Olympus) based on a previously 
described method [41], variation of 10%), and a 
density of 1,710 kg/m3 were used (variation of 10%) 
as measured by obtaining weight/volume for 5 skull 
specimens. Density was determined based on water 
displacement and mass measurement. The 
computational domain contained the skull cap 
(applying the average values for sound speed and 
density), submerged in a hemispherical volume of 
water (speed of sound: 1,500 m/s, density: 1,000 
kg/m3), and the active surface of the transducer.  
The 3D geometry was then subdivided into a 
number of small subdomains (elements), each having 
a defined shape and number of nodes. The element 
size needed to be fine enough to reasonably resolve 
the wave propagation models. A general 
recommendation that was taken into consideration 
was to generate 6-20 elements per dominant 
wavelength along the direction of the wave [39]. A 
mesh convergence study was conducted in the water 
domain while the maximum pressure in the domain 
was monitored. The maximum pressure remained 
stable as the mesh size was reduced from 0.87 to 0.65 
mm (Table S1). Therefore, at a frequency of 286 kHz, 
the element size in water was 0.87 mm, with the 
length of 6 elements equaling the wavelength in 
water. The same strategy was applied to the skull 
domain, where the element size was found to be 1.45 
mm. 
The excitation source was defined as an acoustic 
normal surface velocity at the surface curvature of the 
transducer, with a continuous wave propagation and 
at a 286 kHz frequency (Figure 3D). The vibrating 
surface causes acoustic particles adjacent to the 
surface to move, generating acoustic pressure. For 
purely acoustic phenomena, an acoustic contact is 
given as the interface between the skull and water. 
Note that no fluid-solid interface was defined 
between the skull and water as we assumed negligible 
displacement and deformation of the structure. To 
absorb outgoing acoustic waves from the 
computational domain, an acoustic radiation 
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boundary was applied to the exterior faces of the 
water domain [39] (Figure 3E). 
Thermometry  
Thermometry was performed in a Perspex tank 
(260x160x160 mm) on three fixed sheep calvaria. The 
transducer was fixed on a plate in the bottom of the 
tank, facing up. Thermal measurements were taken 
either with the skull placed on the transducer 
radiating face, or at a distance of 43 mm with a 
coupling cone. Coupling was done with degassed 
water, filling the tank as little as possible such that the 
transducer was fully submerged but the skull only 
contacted the meniscus of the water surface. This 
allowed for an even coupling while minimizing 
possible cooling of the skull sample by the water. The 
transducer settings were the same as those used 
successfully in sheep 5, 7 and 8 (286 kHz, 1.4 MPa 
peak negative pressure, 1 ms pulse duration, 2 Hz 
PRF). The temperature rise in the skull was measured 
using a thermal camera (TrueIR, Keysight), fixed on a 
retort stand 70 cm above the skull. Images were 
captured at a rate of 1/s, and the maximum 
temperature within a target box was recorded. 
External temperatures were measured using T-type 
thermocouples (diameter 600 µm) and a thermometer 
datalogger (EA15 system using EasyView 15 software, 
ExTech Instruments, Nashua, NH). The thermocouple 
was positioned with its stiff wire screwed into the 
HIFU holder, protruding through the central hole of 
the HIFU at the correct length to touch the skull 
surface. The testing apparatus was shielded from air 
currents with a large cardboard box, and allowed to 
equilibrate for 30 min between tests. 
Macroscopic analysis 
For the macroscopic analysis of the extravasation 
of Evans blue, the brain was coronally sliced and fixed 
in neutral-buffered formalin and a true color scan was 
conducted using a desktop photo scanner (V370 
Photo, Epson, Suwa, Japan). Petechiae were counted 
in brains from six sheep. They were defined as blood 
spots <3 mm wide with indistinct edges. Those with 
defined edges, or following the distinct course of a 
blood vessel (characteristic of incomplete perfusion 
leaving unflushed blood vessels), were not counted. A 
700 nm (far-red) scan of each brain section was done 
using a fluorescence scanner (Odyssey Fc, LI-COR, 
Lincoln, NE) for 2 min. Treated areas were delineated 
on each brain slice, as well as three untreated slices 
from each brain (slices 1-3 counting rostral to caudal), 
and the maximum far-red intensity for each area was 
recorded. 
Histological analysis  
Several histological methods were employed. 
For whole-slice analysis, brain blocks were 
cryoprotected in 30% sucrose in PBS and sectioned at 
50 µm on a freezing microtome. 
 For endogenous IgG labeling, slices were 
antigen-retrieved in a 3% sodium lauryl sulfate/2.58% 
sodium citrate solution at 37 °C for 30 min, washed 
once with water and then 3 times for 5 min in PBS. 
Next, endogenous peroxidases were quenched by 
washing in a 3% hydrogen peroxide (in PBS) solution 
for 15 min. The slices were then washed again (3x 5 
min PBS), blocked with 0.5% bovine serum albumin 
for 1 h, and incubated overnight with horseradish 
peroxidase-conjugated donkey anti-sheep IgG 
antibody (A3415, Sigma, St Louis, USA) at a 1:500 
dilution. As a negative control, the antibody was 
omitted. The slices were subsequently washed three 
times in PBS, before developing in Dako DAB+ 
chromogen substrate (Agilent, Santa Clara, USA) 
according to the manufacturer's instructions. The 
slices were then rinsed of excess chromogen three 
times in PBS before being mounted whole onto 
chrome-alum gelatin-coated slides (ProSciTech, 
Townsville, Australia), and dried.  
The mounted slices were defatted with multiple 
5 min washes of water, ethanol, and xylene (2x tap 
water, 70% ethanol, 2x 100% ethanol, 2x xylene, 
reverse back into water), then stained with cresyl 
violet solution (0.1% cresyl violet acetate in 1 M 
sodium acetate, 2% glacial acetic acid) and rinsed 
thoroughly. They were then dehydrated and cleared 
(water-xylene, as above), and coverslip mounted with 
DPX mountant (Thermo Fisher, Sydney, Australia). 
For region of interest analysis, Evans 
blue-stained pieces from sheep 10-12 were excised 
and paraffin embedded and then sectioned at 7 µm 
thickness. Sections 35 µm apart were defatted and 
rehydrated, and stained with either hematoxylin and 
eosin (H&E) or vanadium acid fuchsin (VAF) stain to 
assess cell damage and red blood cell infiltration. 
After staining, slides were cleared and mounted as 
above. To further confirm IgG extravasation, 
fluorescent lectin/IgG co-labeling was performed. 
Rehydrated sections were antigen retrieved, blocked, 
and incubated with lectin biotin conjugate (Sigma) at 
1:250 overnight, washed and then incubated with 
1:500 dilutions of streptavidin conjugated alexa-555 
and anti-sheep IgG-488 ( Life Technologies, Carlsbad, 
USA) for 2 h. Slides were imaged for fluorescence on a 
Diskovery spinning-disk confocal microscope 
(BioVision Technologies, Exton, USA), in bright field 
on an AxioImager microscope (Zeiss Australia, 
Sydney, Australia), and scanned on a slide scanner 
(Metafer4, Zeiss Australia, Sydney, Australia). 
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Table 1. Summary of sheep sonications  
Sheep # 1 2 3 4 5 6 
Frequency (kHz) 500 500 500 500 515 b 286 286 
Sonications (#) 5 6 4 5 2 3 c 6  
Pressure (MPa) 0.6-2.4 2.4 2.4 2.4 1-1.4 1.4 
Pulse duration (ms) 10 10 10 10 1 10 
PRF (Hz) 2 2 2 2 2 2 
Microbubble 
type 
in-house in-house Definity Definity Definity Definity 
Microbubble 
administration 
infusion bolus bolus bolus bolus bolus 
Evans blue administration (delay/min) 10 10 10 10 immediate immediate 
Evans blue-positivity a - - - - N.A. + a + a 
Sheep # 7 8 9 10 11 12 
Frequency (kHz) 286 286 286 286 286 286 
Sonications (#) 5 5 4 11 5 5 
Pressure (MPa) 1.4 1.4 1.4-2.4 1.4-2.4 1.4-2.4 1.4-2.4 
Pulse duration 
(ms) 
1 1 1 1 1 1 
PRF (Hz) 2 2 2 2 2 2 
Microbubble 
type 
Definity Definity Definity Definity Definity Definity 
Microbubble 
administration 
bolus bolus bolus bolus bolus bolus 
Evans blue administration 
(delay/min) 
immediate immediate immediate immediate immediate immediate 
Evans blue-positivity a + a + a N.A. + + + 
a Sonication spot 5 only; b after a transducer recalibration, 515 instead of 500 kHz was used; c sonication spots 1, 2 and 5; N.A., not available 
 
Results 
Study design  
Our non-recovery protocol included a total of 12 
sheep with on average five sonication points each, 
based on the use of a spherically focused HIFU 
transducer (Table 1 and Figure S1).  
 In a pilot study, sheep 1-4 helped to establish the 
general procedures including anesthesia, sonication 
protocol plus microbubble administration, brain and 
skull dissection and the histological analysis.  
 Sheep 5-8 were used to establish reproducibility 
and efficacy in opening the BBB at the base of the 
brain. We also performed ex vivo thermometry, used 
CT scans to create a 3D model of the skull and 
performed simulations of the HIFU and skull in water 
(FEA and UAR analysis), followed by measuring the 
trans-skull acoustic pressure.  
 Sheep 9-12 were used to target areas that include 
the cortex and hippocampus (where plaque pathology 
concentrates in AD) using simulations and 
optimizations based on data obtained with sheep 5-8. 
We introduced in vivo CT imaging and were able to 
predict a cortical/hippocampal focus and sufficient 
pressure to open the BBB in the regions of interest. 
The simulation suggested the use of a 20 mm coupling 
cone, which allowed us to achieve targeted BBB 
opening in sheep.  
BBB opening established in sheep 
The first two cohorts included eight sheep in 
total with an average of five sonication points each 
(Table 1), either placing the transducer directly on the 
skull, aimed at targeting deep, basal brain areas 
(Figure 2A), or with a 43 mm coupling cone, aimed at 
targeting a more shallow focus close to the skull 
(Figure 2B). The sonication spots were chosen without 
relying on image guidance or using stereotaxic 
coordinates; rather, we selected easily palpable 
anatomical features on the skull, which were able to 
stably and repeatedly accommodate the transducer 
assembly (Figure 2C).  
 For the first four sheep, parameters such as 
frequency, microbubble type and delivery, and 
acoustic pressure were varied before gaining 
consistent Evans blue staining in the brain (Table 1). 
Sheep 1 was sonicated using a 500 kHz transducer, 
but failed to reveal Evans blue uptake. A likely 
explanation was insufficient microbubble 
concentration in the circulation due to slow infusion. 
We therefore moved to bolus injections of the 
microbubbles from sheep 2 onwards, and from 
custom-made to Definity microbubbles from sheep 3 
onwards. However, again we failed to achieve overt 
BBB opening as visualized by the absence of Evans 
blue extravasation. We then increased the voltage to 
the maximum output of the amplifier to ensure 
sufficient pressure. This still proved unsuccessful at 
producing an Evans blue signal in the brain, but as 
sheep 4 displayed some subdural hemorrhages at the 
site of sonication, it was apparent that sufficient 
ultrasound energy had reached the brain, but that the 
dye was not extravasated. As the next step, we 
changed the transducer to one with a lower 286 kHz 
frequency to obtain better skull penetration. Further, 
rather than having a 10 min delay between sonication 
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and Evans blue administration, we administered the 
dye immediately after the last sonication. 
Successful Evans blue uptake was consistently 
achieved for sonication location #5 (at the base of the 
brain) in sheep 5-8, using a bolus injection of Definity 
microbubbles, 286 kHz bursts of 1 ms duration, a 1.4 
MPa peak negative pressure, and a PRF of 2Hz, and 
either a 10 ms (sheep 6) or a 1 ms (sheep 5, 7 and 8) 
pulse duration. This was evident when a full anterior 
to posterior series of coronal brain sections was 
visualized in natural color (Figure 4A-B), and in 
fluorescence images of the same slices, with Evans 
blue fluorescence intensity indicated in heat-map 
coloration (Figure 4C-D). A minimum of 5 min delay 
was allowed between sonications to allow for clearing 
of most of the microbubbles from the circulation. To 
visualize BBB opening with an alternative method, we 
stained sections with cresyl violet and anti-sheep IgG, 
revealing pronounced IgG uptake for sonication point 
#5 that matched the Evans blue pattern (Figure 4E-F). 
 
 
Figure 2. Sheep sonication procedure. (A) Application of a transducer directly to the sheep head without a coupling cone to provide a focus at the base of the brain. (B) 
Transducer application to the sheep head using a coupling cone to provide a cortical/hippocampal focus. (C) Example sonication positions. 1: with the transducer being applied 
directly to the head; 2-5: using a coupling cone for the transducer. (D) Illustration of the skull dissection. The blue line indicates the surgical saw cuts around the calvarium. (E) 
After the calvarium was removed intact for ex vivo testing, the brain was exposed and ready to be removed. (F) Illustration of the brain in a cutting block, having been sliced but 
not separated.  
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Figure 3. Simulation process from CT scan to ANSYS FEA. (A) CT scan of the sheep skull used to create the 3D model of the skull cap. (B) Full 3D geometry of the 
skull cap imported into ANSYS shown from above (top) and in cross-section (bottom). (C) The HIFU (black model) was precisely positioned such that the axis of the central hole 
(red line) was aligned with at the sonication spot on the skull cap. (D) Two main domains of water (blue) and skull cap (black) were created. Note that only half of the 
computational domain is shown. (E) 3D pressure contour (FEA result) in the water domain. Note that the skull cap domain has been removed for better visualization. 
 
Together, the BBB at the base of the brain was 
successfully opened (applying the transducer directly 
to the head), whereas in shallow areas (using a 43 mm 
cone) it was not. We next aimed to achieve targeting 
of hippocampal and cortical areas, assisted by 
simulation optimization. We anticipated that we 
would nee a smaller coupling cone than used for 
shallow targeting. 
Acoustic simulations to optimize in vivo 
targeting  
We next performed a 3D simulation of the 
acoustic field of the 286 kHz HIFU in water in the 
absence of a skull using FEA shown as a 2D 
representation (Figure 5A), followed by validating the 
pressure distribution in an AIMS III tank filled with 
water, again in the absence of a skull (Figure 5B). For 
both the simulation and the experiment, the focal zone 
(maximum pressure) was 43 mm distant from the 
outer edge of the transducer. When the signal decay at 
-3 dB (about 0.75 of the maximal normalized pressure) 
was assessed, the only difference between the 
simulated and the measured data was that, for the 
latter, the focal zone was shifted 4 mm towards the 
transducer surface (Figure 5B). This was not 
unexpected considering that the HIFU transducer 
(active diameter: 64 mm, radius of curvature: 59.97 
mm, f-number = 0.93) deviated from the provided 
specifications (diameter: 64 mm, radius of curvature: 
64 mm, nominal f-number =1.0) (see also: [42]).  
 Next, 3D simulations were performed of the 
sheep skull cap in water (with water as a reference) 
using two sonication spots that were 14 mm apart 
(Figure 6A) to obtain a pressure map at a defined 
plane inside the cap (Figure 6B). The simulations 
were again validated in the AIMS III tank, positioning 
the skull cap by means of a 3D-printed holder to 
achieve the same position and angle as in the 
simulation (Figure 6C), and the pressure map was 
obtained at this plane. For both the simulation and 
experimental validation, the absolute pressure value 
was normalized for the maximum pressure in water 
in the absence of the skull cap. For both sonication 
spots (Figure 6D-E), the location of the maximum 
pressure in terms of depth and the pressure 
distribution were in good agreement with the 
simulation. This validated the FEA, which we then 
used to optimize the positioning of the HIFU and the 
targeting of the focus to reduce transmission loss.  
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Figure 4. Obicodilation of areas at the base of the brain visualized with Evans blue. (A) Full series of coronally sliced brain sections (sheep 5), scanned in natural 
color. Evans blue uptake is seen as a blue mark in slice 8. (B) Close-up view of slice 8. (C) LI-COR fluorescence images taken of the same slices at 700 nm, demonstrating the 
presence of Evans blue by heat-map coloration. (D) LI-COR fluorescence close-up view of slice 8. (E-F) To visualize BBB opening with an alternative method, sections were 
stained with cresyl violet and anti-sheep IgG, revealing pronounced IgG uptake ((F) is inset from (E)). Scale bars: 10 mm.  
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Figure 5. Validation of a 3D simulation of the 286 kHz HIFU acoustic field in water in the absence of a skull. (A) A 2D representation of the focus of the HIFU 
in water (showing the active surface of the HIFU in white). (B) Graph showing the normalized pressure profile in the experiment compared to the simulation as a function of the 
distance from the edge of the HIFU. 
 
 Two sonication spots 20 mm apart (to ensure 
that the spots were not overlapping) were modeled in 
the simulations in which the cone height (distance 
between the active surface of the HIFU and the skin 
surface) was changed from 0 mm to 40 mm in 10 mm 
increments. We determined that the thickness of the 
scalp varied between 4 mm and 5 mm, and added this 
distance to the simulation (Figure 7A), modeling its 
acoustic properties as water [43]. In the absence of a 
cone, the -6 dB contour was 35x6 mm at the base of the 
brain, and the skull base (Figure 7B). With a 10 mm 
cone, the -6 dB contour was reduced to 30x6 mm and 
the focus was repositioned axially towards the face of 
the transducer, overlapping the base of the brain and 
the hippocampus (Figure 7C). With a cone height of 
20 mm, cortical and hippocampal areas were targeted 
within the -6 dB pressure contour of size 35x6 mm and 
this positioning yielded the highest focal maximal 
pressure of 0.7 (normalized pressure) estimating 30% 
attenuation caused by the sheep skull cap (Figure 7D). 
By increasing the cone height to 30 mm and 40 mm, 
the focus moved towards the face of the transducer 
and energy was deposited on the calvarium and 
outside the skull where the majority of the wave’s 
energy was reflected by the skull cap surface (Figure 7 
E-F).  
 When establishing a pressure profile at a -6 dB 
pressure contour for both sonication spots (Figure 
7G), the targeting area was also confirmed for spot 2, 
with a slightly higher pressure. One should note that 
for a given cone height, for the two sonication spots 
examined, the HIFU targeted the brain at a similar 
depth (with a displacement of ± 2 mm) and creating a 
similar focal size (variation of 4 mm) (Figure 7H). We 
thus determined that the 20 mm cone was most 
suitable as it targeted the cortex and hippocampus, 
areas of interest in AD and in which the -6 dB 
pressure contour of the focus would provide the 
required pressure for opening BBB (sheep 9-12).  
Predicting attenuation of the waveform by the 
sheep skull  
To estimate how much acoustic energy reaches 
the brain at the focal point in cortical areas (using a 20 
mm cone), we tested ex vivo skulls from three sheep in 
a test bed (Figure 8A-B), by applying a recently 
derived analysis, UAR. UARs in the presence or 
absence of a sheep skull were computed at the focal 
point. The UAR data in the absence (water only) and 
presence of a skull are shown at the cortical/ 
hippocampal focus (Figure 8C). We always compared 
two adjacent peaks (with the blue line corresponding 
to the water condition and the red line to the skull 
condition), and assessed the amplitude and time 
delay (Figure 8D). The UAR peak time comparison 
revealed that the presence of the sheep skull reduced 
the delay of sound compared to water (because the 
speed of sound in the sheep skull is higher than that of 
water). The reduction in the delays varied between 
1.16 µs and 1.31 µs (sheep 12), 0.8 µs and 1.24 µs 
(sheep 11), and 1.18 µs and 1.16 µs (sheep 10) for the 
focal point. We also found that the amplitude ratio of 
the UAR peaks varied between 30% and 50% for 
sheep 12, 32% and 60% for sheep 11, and 31% and 54% 
for sheep 10. This shows that the attenuation caused 
by the sheep skull cap is around 40%, 47%, and 40% 
on average, respectively.  
 Theranostics 2018, Vol. 8, Issue 9 
 
 
http://www.thno.org 
2593 
 
Figure 6. Validation of 3D simulations of sheep skull cap in water. (A) Two sonication spots 1 and 2 close to the center and on the right side of the cap are shown. (B) 
The pressure map location is shown by a blue surface inside the sheep skull cap in a cross-sectional view. (C) The skull cap and HIFU were fixed by means of a 3D printed holder 
in the AIMS III tank where the needle hydrophone measured the pressure inside the cap. (D-E) Pressure contours are presented for both the simulation (Sim.) and experiment 
(Exp.) at sonication spots 1 and 2.  
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Figure 7. Optimization of the 3D simulation for two sonication spots while systematically changing the cone height. The pressure distribution in the skull bone 
was removed and the normalized maximal pressure was defined inside the cap. (A) Cross-sectional view of the HIFU, cone and skull cap. (B) In the absence of a cone, the 
normalized maximum pressure (P) inside the cap was calculated as 0.6. The focus of HIFU (FoH) was at the base of the brain. The yellow dashed oval represents the entire brain. 
(C) With a cone height of 10 mm, P was 0.62 and the focus was positioned corresponding to the base of the brain and hippocampus. (D) With a cone height (CH) of 20 mm, 
a focus was obtained in the putative cortical and hippocampal brain. (E) With a cone height of 30 mm, the focus was in the skull cap bone. (F) With a cone height of 40 mm, the 
focus was outside of the brain. (G) The normalized pressure profile of two sonication spots at the -6 dB contour is shown as a function of changing cone height. (H) For each 
cone height, the actual size of the focus is shown and registered with a CT scan of the sheep head.  
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Figure 8. Attenuation. (A) Block diagram of the ultrasound test bed. The ‘Transmit stream’ is shown in blue, and the ‘Receive stream’ is shown in green. The same transmit 
stream is also used for the in vivo and thermometry experiments. (B) Experimental setup for estimating the trans-skull acoustic pressure. The HIFU transducer was placed in a 
holder in the Onda tank filled with degassed water. The skull was positioned with a 20 mm cone above the HIFU radiating surface, and the hydrophone sensor was positioned 
at the cortical focus. HIFU transducer, high intensity focused ultrasound transducer; AMP, amplifier; PC, personal computer. (C) The ultrasound acoustic response (UAR) in 
water and in the presence of sheep 12 skull. (D) Calculation of the amplitude ratio and the delay reduction at cortical focal points for sheep 10, 11 and 12.  
 
Absence of significant sheep skull heating  
HIFU is predominantly used for the thermal 
ablation of either tumor tissue or by ablating thalamic 
tissue in order to correct a movement disorder [44]. 
Tissue heating is therefore a concern and must be 
considered as a side-effect for any non-thermal HIFU 
therapy. We determined skull heating by in vitro 
thermometry, directing an infrared camera at the skull 
to measure its interior surface temperature, and using 
a thermocouple to measure its exterior temperature. 
Infrared images are shown after 2 min sonication with 
and without a coupling cone (Figure 9A-B) using the 
same sonication parameters that were applied to 
sheep 5, 7 and 8 (286 kHz frequency, 1.4 MPa peak 
negative pressure, 1 ms pulse duration, 2 Hz PRF). 
The temperature after 2 min was recorded at the 
interior surface of the skull, measured with an 
infrared camera, and the exterior surface, measured 
with a thermocouple, with n=3 for all groups. Mean (± 
SD) for thermocouple measurements were as follows: 
baseline 21.40 °C (0.78), without cone 21.30 °C (0.46), 
and with cone 21.26 °C (0.40). Mean (± SD) for 
infrared measurements were as follows: baseline 21.73 
°C (0.40), without cone 22.70 °C (0.50), and with cone 
23.03 °C (0.06) (Figure 9C); thus, the maximum 
heating recorded was 1.76 °C. Assuming an average 
sheep body temperature of 35.70 °C, an additional 
1.76 °C for two min yields a maximum temperature of 
37.46 °C. Cumulative effective minutes at 43 °C 
(CEM43) is used to describe a thermal dose that 
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correlates with tissue damage [45]. In a living sheep 
with an average body temperature, the measured 
heating would result in a CEM43 of 0.0002, orders of 
magnitude below the lowest threshold for damage, 
CEM43 of 12.3, as described by McDannold and 
colleagues in rabbits [46].  
BBB opening of cortical areas confirmed 
macroscopically and histologically  
Considering that the HIFU generates a large 
focus, we aimed to achieve a pressure level at the -6 
dB contour for BBB opening in a volume of 35x6 mm 
as estimated by FEA. According to our UAR analysis 
of an estimated 40% attenuation, this volume could be 
opened with a maximum pressure in water of 1.4 MPa 
resulting in 0.42 MPa in brain, 2.1 MPa in 0.63 MPa, 
and 2.4 MPa in 0.72 MPa, respectively. 
 Based on the outcome of the simulation, we used 
a shorter 20 mm coupling cone and a higher pressure 
(2.1 MPa and 2.4 MPa, the maximum achievable in 
water) to open a wider area of the brain for the third 
cohort of four sheep, with an average of five 
sonication points each (Table 1). Only sheep 10-12 
were further analyzed (sheep 9 was omitted for 
technical reasons). We achieved Evans blue staining 
over wide areas of the brain, including cortex and 
hippocampus (Figure 10A). Some of these treatments, 
however, also induced some hemorrhaging, 
particularly in white matter tracts (Figure 10B).  
The analysis of petechiae in slices taken from 
sheep of cohorts 2 and 3 using 1 ms pulses revealed 
that they increased in number with sonication 
pressure. Unsonicated areas (control, n=9), or areas 
sonicated with 1.4 MPa (n=8), 2.1 MPa (n=15), and 2.4 
MPa (n=19) were grouped. Mean (± SD) values for 
each group were as follows: control 0.44 (0.88), 1.4 
MPa 0.63 (0.52), 2.1 MPa 5.87 (10.88), or 2.4 MPa 8.74 
(9.14) (Figure 10C). 
 
 
Figure 9. In vitro measurement of the skull bone temperature after 2 min sonication. (A-B) Infrared camera images of an ex vivo sheep skull at 286 kHz, 1.4 MPa, 1 
ms, 2 Hz PRF. (A) Skull placed directly onto the transducer, and (B) using a coupling cone. (C) Mean (± SD) temperature measurements taken from the outer skull surface with 
a thermocouple, and the inner skull surface using an infrared camera (all groups, n=3).  
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Figure 10. Analysis of Evans blue uptake in sonicated sheep brain. (A) Coronal section of fixed brain, showing extravasation primarily in cortical and hippocampal areas 
(top right of section). Cortical areas are delineated with a brown line and hippocampal areas with a dashed brown line. (B) Coronal section showing blue staining together with 
petechiae, primarily in white matter (left side of section). (C) Plot of petechia numbers within brain areas for a range of peak negative pressures. (D-E) 700 nm far-red scans of 
sections in A and B, with heat-map intensity coloration. (F) Plot of maximum 700 nm staining intensity in brain areas treated with 1.4, 2.1 and 2.4 MPa peak negative pressure and 
control. 
 
Far-red scans also showed the extent of Evans 
blue extravasation throughout the brain, 
corresponding to the sonicated areas (Figure 10D-E). 
Staining intensity was quantifiable from these scans, 
and this increased with sonication pressure (Figure 
10F). Unsonicated areas (control, n=18), or areas 
sonicated with 1.4 MPa (n=14), 2.1 MPa (n=41), or 2.4 
MPa (n=34) were grouped. Mean (± SD) values for 
each group were as follows: control 0.74 (0.31), 1.4 
MPa 1.88 (1.14), 2.1 MPa 3.08 (1.92), or 2.3 MPa 3.48 
(1.46). 
 Obicodilation was also confirmed histologically. 
Extravasated sheep IgG provided an endogenous 
marker, and staining against it confirmed the 
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macroscopic findings of Evans blue extravasation in 
treated areas (Figure 11). Areas of BBB opening 
showing widespread extravasation of IgG with 
leakage from capillaries (Figure 11 A, C), whereas 
areas without BBB opening show little or no labeling 
for IgG (Figure 11 B, D). Cellular damage was 
assessed by a vanadium acid-fuchsin (VAF) stain of 
paraffin-embedded brain sections with only a few 
examples of VAF-positive (ischemic) neurons (data 
not shown). H&E staining was employed on 
paraffin-embedded brain sections to assess the 
presence of microhemorrhages as shown for areas 
with BBB opening (Figure 12A-D), revealing 
microhemorrhages in many of the areas treated with 
>2 MPa and in the center of the focus, but also more 
peripheral large areas with BBB opening in the 
absence of red blood cell extravasation. Some 
unflushed blood vessels were also seen. Because of 
the size of the sheep brain and the large focal areas it 
was not possible to assess potential microscopic 
damage in a complete manner. In addition, whether 
these changes persist with time (beyond 1 h) has not 
been assessed, as the sheep underwent a non-recovery 
protocol.  
 
 
Figure 11. IgG and vasculature staining. (A, C) Area of BBB opening showing widespread extravasation of IgG (sheep IgG, in green) with leakage from capillaries (lectin 
staining, in red). Area without BBB opening shows little or no labeling for IgG. (B, D) High magnification imaging of leaky blood vessels in (C) showing a high concentration of IgG 
around vessels as well as diffusion of IgG into the brain parenchyma, as well as binding or uptake of IgG into cells. Scale bar: 20 µm (A, C), 50 µm (B, D). 
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Figure 12. Hematoxylin & Eosin staining. In areas of BBB opening we detected erythrocyte extravasations by H&E staining at the focal zone when higher pressures were 
used (A-B). BBB opening could also be achieved without occurrence of erythrocyte extravasation as shown in (C-D). Scale bar: 100 μm 
 
Discussion  
In the present study we have established sheep 
as a preclinical model for ultrasound-mediated BBB 
opening. We were guided by the notion that this 
species shares many important brain and skull 
features with humans. In translating rodent studies to 
the human setting, additional factors including body 
size and source (non-laboratory bred) were also 
considered important in order to present as many 
challenges to the technique as may be reasonably 
encountered in a clinical setting. To our knowledge, 
this study is the first demonstration of obicodilation in 
sheep, although the technique has been successfully 
applied in other large, complementary animals such 
as macaques [28,47], beagles [31] and pigs [48]. Brain 
size is broadly similar between these species and, 
unlike rodents, all have a gyrencephalic brain (Figure 
1). Sheep represent an attractive model because their 
skull thickness and composition are similar to those of 
humans, they are readily available, relatively easy to 
use experimentally, and brain atlases are well 
documented for this species [49]. Sheep also have a 
body weight profile closer to humans and this is 
useful for optimizing microbubble kinetics and 
dosing in relation to BBB opening. 
 AD pathology is characterized by Aβ plaques 
and Tau tangles [50]. Of note, similar to dogs [51], 
sheep do naturally develop an AD-like pathology 
[34]. One reason may be that the Aβ sequence 
(different from rodents) is identical between sheep, 
dogs, pigs and humans [52], and that sequences 
important for Tau pathology are also conserved [34]. 
In order to reproduce AD pathology in rodents, 
transgenic mice have been generated that 
over-express human AD-related genes [50]. However, 
transgenic sheep are not available. Still, when four 
8-year-old and a single 14-year-old sheep were 
analyzed, Tau tangle-like structures were identified in 
3 of the four 8-year-old sheep, and Aβ-immuno-
positive plaques were identified in all animals, 
although most plaques were diffuse [34]. AD 
transgenic pigs have recently been generated [53], but 
the thickness of the pig skull continues to increase 
with aging [54], making this species less suitable for 
aged, AD, or longitudinal studies. Minipigs also 
possess large, air-filled sinuses atop the skull, which 
would block ultrasound transmission. 
 Macaques have the advantage that cognitive test 
batteries are available [29,55]. Interestingly, given that 
cognitive decline is a major therapeutic target in AD, a 
recent study used tests of executive function 
(discrimination learning, reversal learning and 
attentional set-shifting) in sheep and found that not 
only could they perform discrimination learning and 
reversals, but they could also perform the 
intradimensional and extradimensional set-shifting 
tasks that are sensitive tests of cognitive dysfunction 
in humans. Moreover, their performance on these 
shifts mirrored that seen in humans and macaques 
[56].  
  A number of different ultrasound parameters 
have been used successfully to open the BBB in large 
animals. In macaques, 500 kHz ultrasound was 
applied at a peak negative pressure of 250-600 kPa 
with a 10 ms pulse length, repeated at 2 Hz for 2 min 
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[57]. Also in macaques, a phased array system applied 
220 kHz ultrasound with a range of peak negative 
pressures (223-400 kPa in situ) to open the BBB or to 
generate lesions at higher pressures [58]. In beagle 
dogs, 280 kHz ultrasound was applied with a peak 
negative pressure ranging from 1-1.2 MPa using an 
acoustic emissions-based controller that reduced the 
pressure by 50% upon detection of subharmonics. 
Pulse lengths of 10 ms and shorter achieved BBB 
opening in mice [59]. Our results demonstrate that 1 
ms pulses at low frequencies suitable for trans-skull 
transmission (such as 286 kHz) are capable of 
achieving obicodilation in sheep. Shorter pulse 
lengths may be more advantageous than longer 
pulses by reducing standing wave effects [60]. PRF 
varied between 0.3 Hz and 10 Hz in these studies. 
 In the first instance, we aimed to use the HIFU 
transducer with a relatively large focus in order to 
treat larger areas of the brain, which is particularly 
important for diseases involving the entire brain such 
as AD. Thereby, the breadth of brain tissue 
heterogeneity including complex gyri and sulci, 
compartmentalized gray and white matter, and large 
ventricles and blood vessels is being captured [33]. 
These are acoustically distinct structures and it is 
important to account for them when refining the 
obicodilation technique [61]. We first aimed to target 
deeply situated, basal brain areas because direct 
transducer placement on a flat area of skull was 
predicted to give the best transmission of ultrasound 
through the skull bone. In later sheep, we used a cone 
of optimal height (based on simulations) of 20 mm to 
enhance transmission and target cortical and 
hippocampal brain areas, relevant to AD. Transcranial 
transmission reduces the effective size of the focus in 
which there is a tightly focused beam of high enough 
peak negative pressure to open the BBB. As we 
eventually aim to treat large areas of the brain, we 
enlarged the volume of sheep brain with BBB opening 
by generating peak negative pressures evidently 
above the threshold for BBB opening, which 
sometimes resulted in damage in the form of 
bleeding. Other transducer geometries should be 
investigated to treat a large focal area while operating 
below the threshold for damage. Another approach 
that is being pursued is to use a phased array to 
electronically steer the focus and sonicate each focal 
point sequentially using power levels calibrated by 
harmonic or subharmonic acoustic emissions 
detection. We believe sheep, due to their skull 
properties and large complex brains, would be a good 
experimental animal with which to test transducers of 
different geometries, volume steering by phased 
arrays, and acoustic emissions detection through a 
human-like skull. 
 To visualize BBB opening, we used Evans blue 
extravasation as done by us previously [19]. Despite 
this dye being a commonly used marker of BBB 
permeability, concerns have been raised about its 
appropriateness as it can exist bound to serum 
albumin and as a smaller unbound fraction [62]. As a 
complementary method, we also performed 
immunolabeling for sheep IgG (that is twice as large 
as albumin). In combining IgG with either Nissl or 
lectin staining, extravasation from vasculature into 
parenchyma was evident. Together, this 
demonstrated that the BBB is also penetrable for 
larger molecules. Other techniques that could be 
considered for the visualization of BBB opening 
include the use of fluorescently tagged dextrans of 
different sizes [63] or the in vivo measurement of the 
influx of gadolinium using MRI [64].  
From our basic sonication protocol, it was 
apparent that higher peak negative pressures 
delivered to sheep brain resulted in increased 
extravasation of both Evans blue and red blood cells, 
the latter being potentially damaging. We found that 
delivering 1.4 MPa peak negative pressure gave 
Evans blue signal with minimal blood; however, 
future researchers are advised to optimise the 
parameters involved in the technique. Frequency and 
microbubble concentration being equal, pulse 
duration, duty cycle, PRF and peak negative pressure 
all affect the safety and efficacy of obicodilation.  
 In targeting the brain, damage of the skull and 
the brain in the focal area need to be avoided. Because 
attenuation of ultrasound can occur as a result of 
absorption, resulting in heating [65], we estimated the 
heating effects of our verified sonication parameters 
in vitro. The energy delivered due to the sonication 
parameters used for BBB opening was incapable of 
heating an ex vivo skull more than 2 degrees above 
baseline temperature, both with and without a 
coupling cone. It is expected that the heat dissipation 
measured in ex vivo bone is lower than in vivo, as 
reported previously [66]. This lack of heating 
indicates that, when using the established sonication 
parameters for opening the BBB, skull or tissue 
heating is unlikely a concern. Our study also shows 
when employing H&E that higher pressure was 
associated with erythrocyte extravasation in the 
center of the focus, but tissue integrity was 
maintained even in areas with the largest bleeds. In 
future studies, a recovery protocol may be included to 
determine long-term safety of obicodilation in sheep, 
and to assess tissue integrity at longer time points.  
 In conclusion, the thick skull bone and 
gyrencephalic brain of sheep presents them as a 
physically realistic model of obicodilation that 
complements the existing suite of models. This, 
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together with their natural AD-like aggregates in 
aging, positions the sheep as a clinically relevant 
model of obicodilation in dementia research.  
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